首页> 外文期刊>Indian drugs >PHARMACOLOGICAL STUDIES OF AMWANNICH BASE PRODRUGS OF IBUPROFEN
【24h】

PHARMACOLOGICAL STUDIES OF AMWANNICH BASE PRODRUGS OF IBUPROFEN

机译:布洛芬氨苯酚基药物的药理研究

获取原文
获取原文并翻译 | 示例
           

摘要

The final efficacy and safety of N-Mannich base prodrugs of amides of ibuprofen, IBMB-M and IBMB-P, were confirmed by performing pharmacological studies on animals. The antiinflammatory activity of the prodrugs was evaluated by rat paw edema method. The results confirmed that both the prodrugs have sufficient antiinflammatory activity. The gastrointestinal toxicity was evaluated on fasted rat model and these studies confirmed that both the prodrugs had remarkably reduced gastrointestinal ulceration. Finally, acute toxicity studies were performed on rats by administering the prodrugs at the dose level equivalent to LD_50 of ibuprofen and higher doses. The LD_50 of both the prodrugs was much higher than the LD_50 of ibuprofen, which confirmed the safety of the prodrugs.
机译:通过对动物进行药理研究,确认了布洛芬,IBMB-M和IBMB-P酰胺的N-曼尼希碱前药的最终疗效和安全性。用大鼠爪水肿法评价前药的抗炎活性。结果证实两种前药均具有足够的抗炎活性。在禁食的大鼠模型上评估了胃肠道毒性,这些研究证实,这两种前药均显着减少了胃肠道溃疡。最后,通过以等于布洛芬的LD_50和更高剂量的剂量施用前药对大鼠进行了急性毒性研究。两种前药的LD_50均高于布洛芬的LD_50,这证实了前药的安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号